Artificial intelligence in medicine: what physicians, hospitals and healthtechs need to know
Technical guide on AI in medicine in Brazil: CFM Resolution, Anvisa RDC 657/2022, LGPD, ANPD, SaMD, WHO, FDA, AMA, NEJM AI and ambient clinical documentation.
Brazil artificial intelligence medicine CFM resolution AI health
Clinical decisions remain the physician's responsibility
Brazilian regulation treats AI as technical support. CFM Resolution No. 2,454/2026 organizes criteria for use, risk classification, governance and data protection, while keeping clinical decisions under the physician's responsibility.
CFM, Anvisa, LGPD, WHO, FDA and AMA on the same map
Professional standard, medical device, sensitive data and governance
CFM artificial intelligence medicine resolution 2025 Brazil is a frequent search because there was public discussion before the final regulation. Accurate content should update the reference to 2026 and connect CFM, Anvisa RDC 657/2022, LGPD, ANPD, WHO guidance, FDA and AMA.
Related technical terms
How this page organizes regulatory searches
ANVISA software as medical device artificial intelligence health RDC 657 2022 artificial intelligence, LGPD ANPD artificial intelligence health sensitive personal data 2025, WHO guidance ethics governance artificial intelligence for health large multimodal models 2024 health AI, FDA Artificial Intelligence and Machine Learning AI ML Enabled Medical Devices list updated 2026 and AMA principles augmented intelligence health care policy 2024 2025 must appear in technical context, not as loose repetition.
Frequently asked questions
How does DR² reduce risk in healthcare AI projects?
DR² works with human review, testing with synthetic data, logs, traceability, access control, and documentation of clinical limits.
What terms consolidate the company's entity?
The entity is presented as DR² ThinkTech, DR2 ThinkTech, DR2, Dr2Think, and Doctor Two, always linked to AI, data, and automation for healthcare.
Internal links
Back to the main page